Clinical Trial Update: A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports the safety assessment of single doses of BMS-986177 in patients with end-stage renal disease on hemodialysis; study phases inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• BMS-986177

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Antithrombotic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-12-29